Skip Navigation

This Article
Right arrow Print PDF (4457K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by han, P.
Right arrow Articles by Barsoum, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by han, P.
Right arrow Articles by Barsoum, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1991, Vol. 19, No. 25 7225-7229
© 1991

Foreword

Transaction of heterologous promoters by HIV–1 tat

Paula han, Rhonda Brown and James Barsoum*

Biogen, Inc., Fourteen Cambridge Center Cambridge, MA 02142, USA

*To whom correspondences should be addressed

To determine whether HIV–1 tat can transactivate a heterologous promoter lacking HIV sequences other than the TAR element, TAR was placed downstream of the chicken ß-actin promoter. Tat increased expression directed by the actin-TAR promoter to a degree equal to tat induction of the HIV–1 LTR. Optimal transactivation was observed when TAR was positioned downstream of the actin promoter such that the expected cap site of transcripts from this promoter would be the same as In transcripts directed by the HIV–1 LTR. Tat was able to transactivate, though to a lesser extent, a promoter consisting solely of a TATA element fused to TAR. Thus, tat Induction does not require HIV–1 LTR promoter sequences other than TAR. Tat, when fused to the DNA binding domain of BPV–1 E2, was able to transactivate a truncated SV40 promoter containing upstream E2 binding sites, indic ating that tat may be capable of transactivation when directed by a DNA binding protein to an upstream site in a heterologous promoter lacking all HIV sequences. Substitution of Ala for Lys at position 41 of tat in the tat-E2 fusion, a mutation which dramatically decreases tat transactivation of the HIV–1 LTR, eliminated this fransactlvation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
C. A. Parada, J.-B. Yoon, and R. G. Roeder
A Novel LBP-1-mediated Restriction of HIV-1 Transcription at the Level of Elongation in Vitro
J. Biol. Chem., February 3, 1995; 270(5): 2274 - 2283.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.